Testosterone Transdermal System

DRUG5 trials

Sponsors

Warner Chilcott

Conditions

Hypoactive Sexual Desire DisorderHypoactive Sexual Desire Disorder (HSDD)

Phase 3

Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido

CompletedNCT00331123

Warner ChilcottHypoactive Sexual Desire Disorder

Start: 2002-05-31End: 2006-07-31Updated: 2013-04-17

Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido

CompletedNCT00331214

Warner ChilcottHypoactive Sexual Desire Disorder

Start: 2002-06-30End: 2006-07-31Updated: 2013-04-17

Study of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido

CompletedNCT00338312

Warner ChilcottHypoactive Sexual Desire Disorder

Start: 2002-06-30End: 2006-07-31Updated: 2013-04-17

Study to Assess the Efficacy/Safety of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido

CompletedNCT00349791

Warner ChilcottHypoactive Sexual Desire Disorder (HSDD)

Start: 2002-06-30End: 2003-10-31Updated: 2013-04-17

Endometrial Safety Study of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women

CompletedNCT00467259

Warner ChilcottHypoactive Sexual Desire Disorder

Start: 2007-04-30End: 2009-01-31Updated: 2011-12-15